ReviewClinical & translational immunology2022

LUNG group 2 innate lymphoid cells as a new adjuvant target to enhance intranasal vaccine efficacy against influenza.

Clare M Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.